Skip to main content
HeartCited

Potassium لـ High Blood Pressure (Hypertension)

B الأدلة تدعم ذلك تجربة عشوائية واحدة على الأقل، مع نتائج متسقة في معظمها.

WHO conditional recommendation. Meta-analysis: systolic -3.49 mmHg. DASH diet (4,700 mg K/day) reduces systolic BP by 8-14 mmHg. Potassium-enriched salt substitutes reduced stroke risk by 14% in a 2022 Lancet study.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dpotassium\u0026condition\u003Dhigh\u002Dblood\u002Dpressure'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

الخلاصة

WHO conditional recommendation. Meta-analysis: systolic -3.49 mmHg. DASH diet (4,700 mg K/day) reduces systolic BP by 8-14 mmHg. Potassium-enriched salt substitutes reduced stroke risk by 14% in a 2022 Lancet study.

Key Study Findings

Case Reports n=1
Pseudo-Hyperaldosteronism Arising from Licorice Cough Syrup Self-Ingestion: A Case Report.
Dose: Licorice cough syrup (glycyrrhiza glabra) مقابل: None Outcome: Hypokalemia, hypertension, metabolic alkalosis التأثير: None None

المجتمع المدروس: Single patient with licorice intoxication

Case Reports 13.0 weeks
A case report of Gitelman syndrome in children.
Dose: 3 g مقابل: None Outcome: pain reduction التأثير: None None

المجتمع المدروس: Hypokalemia

Case Reports n=1
Hypokalemia-induced rhabdomyolysis as the first symptom of primary aldosteronism: a case report and literature review.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: 65-year-old woman with primary aldosteronism

Meta-Analysis n=1258
Safety and Efficacy of Spironolactone in Dialysis-Dependent Patients: Meta-Analysis of Randomized Controlled Trials.
Dose: 25 mg/day (typical) مقابل: Placebo or standard care Outcome: All-cause mortality التأثير: RR=0.42, P<0.0001 P<0.0001

المجتمع المدروس: Dialysis-dependent ESRD patients

Case Reports n=1
Bilateral Adrenalectomy in a Patient With Refractory Primary Aldosteronism Due to Adrenal Hyperplasia.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: Patient with refractory primary aldosteronism

Other 8 weeks
Chronic Metabolic Acidosis Elicits Hypertension via Upregulation of Intrarenal Angiotensin II and Induction of Oxidative …
Dose: 150 g مقابل: None Outcome: whether the rats were acidotic, blood pH was … التأثير: None None

المجتمع المدروس: None

Key Statistics

22

الدراسات

1600

المشاركون

Positive

B

التقييم

Referenced Papers

American family physician 2019 49 اقتباسات
Clinical toxicology (Philadelphia, … 2016 25 اقتباسات
Acta medica Iranica 2016 10 اقتباسات
Pharmacoepidemiology and drug … 2011 26 اقتباسات
Heart disease and … 1994
European heart journal 1985 23 اقتباسات
Drug intelligence & … 1981 7 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

supplements:
Typically 99 mg/dose (FDA limit per unit)
dashdiettarget:
4,700 mg/day
whorecommendation:
3,510 mg/day from food

الحد الأعلى: No UL for dietary potassium in healthy individuals; supplemental potassium should be supervised

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
Licorice cough syrup (glycyrrhiza glabra) -- Negative 1
3 g 13.0 weeks Mixed --
None -- Mixed 1
25 mg/day (typical) -- Positive 1258
None -- Mixed 1
150 g 8 weeks Neutral --
None -- Mixed --
20 mg -- Positive --

أفضل وقت للتناول: With meals to reduce GI irritation; divide supplemental doses throughout the day

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Gastrointestinal irritation (nausea, vomiting, diarrhea)
  • Hyperkalemia risk in patients with renal impairment
  • Cardiac arrhythmias at excessively high serum levels

التفاعلات المعروفة

  • ACE inhibitors (increased hyperkalemia risk)
  • ARBs (increased hyperkalemia risk)
  • Potassium-sparing diuretics (increased hyperkalemia risk)
  • NSAIDs (may increase potassium retention)

الحد الأقصى المسموح به: No UL for dietary potassium in healthy individuals; supplemental potassium should be supervised

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Potassium help with High Blood Pressure (Hypertension)?
Based on 22 studies with 1,600 participants, there is moderate evidence from clinical studies that Potassium may support High Blood Pressure (Hypertension) management. Our evidence grade is B (Good Evidence).
How much Potassium should I take for High Blood Pressure (Hypertension)?
Studies have used various dosages. A commonly studied range is Typically 99 mg/dose (FDA limit per unit). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Potassium?
Reported side effects may include Gastrointestinal irritation (nausea, vomiting, diarrhea), Hyperkalemia risk in patients with renal impairment, Cardiac arrhythmias at excessively high serum levels. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Potassium and High Blood Pressure (Hypertension)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 22 peer-reviewed studies with 1,600 total participants. The overall direction of effect is positive.

Potassium لحالات أخرى

References

  1. [1] Chien-Chun Liao et al.. Reports (MDPI). 2024. Pseudo-Hyperaldosteronism Arising from Licorice Cough Syrup Self-Ingestion: A Case Report. doi:10.3390/reports7040085 PubMed
  2. [2] Jing Ying et al.. Medicine (Baltimore). 2023. A case report of Gitelman syndrome in children. doi:10.1097/MD.0000000000033509 PubMed
  3. [3] Jing Liu et al.. Front Med (Lausanne). 2022. Safety and Efficacy of Spironolactone in Dialysis-Dependent Patients: Meta-Analysis of Randomized Controlled Trials. doi:10.3389/fmed.2022.828189 PubMed
  4. [4] Rongfeng Han et al.. Ann Palliat Med. 2022. Hypokalemia-induced rhabdomyolysis as the first symptom of primary aldosteronism: a case report and literature review. doi:10.21037/apm-21-3010 PubMed
  5. [5] Luis Marín-Martínez et al.. Cureus. 2022. Bilateral Adrenalectomy in a Patient With Refractory Primary Aldosteronism Due to Adrenal Hyperplasia. doi:10.7759/cureus.24267 PubMed
  6. [6] Dinesh Aryal et al.. Antioxidants (Basel). 2020. Chronic Metabolic Acidosis Elicits Hypertension via Upregulation of Intrarenal Angiotensin II and Induction of Oxidative Stress. doi:10.3390/antiox10010002 PubMed
  7. [7] Neetika Garg et al.. Clin Transplant. 2020. Prevalence of primary aldosteronism in hypertensive kidney transplant recipients: A cross-sectional study. doi:10.1111/ctr.13999 PubMed
  8. [8] Mary Carpenter et al.. Am Fam Physician. 2019. Clinically Relevant Drug-Drug Interactions in Primary Care. PubMed
  9. [9] Betty S Chan et al.. Clin Toxicol (Phila). 2016. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). doi:10.1080/15563650.2016.1175620 PubMed
  10. [10] Sedighe Moradi et al.. Acta Med Iran. 2016. A Woman with Normotensive Primary Hyperaldosteronism. PubMed
  11. [11] Alfredo Rossi et al.. Recent Pat Inflamm Allergy Drug Discov. 2012. Minoxidil use in dermatology, side effects and recent patents. doi:10.2174/187221312800166859 PubMed
  12. [12] Pernelle Noize et al.. Pharmacoepidemiol Drug Saf. 2011. Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals. doi:10.1002/pds.2128 PubMed
  13. [13] Deepani Rathnayake et al.. Dermatol Clin. 2010. Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. doi:10.1016/j.det.2010.03.011 PubMed
  14. [14] Y Jammes et al.. J Intern Med. 2005. Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. doi:10.1111/j.1365-2796.2005.01452.x PubMed
  15. [15] T Rickman et al.. Am J Kidney Dis. 2001. Hypokalemia, metabolic alkalosis, and hypertension: Cushing's syndrome in a patient with metastatic prostate adenocarcinoma. doi:10.1016/s0272-6386(01)80134-7 PubMed
  16. [16] E Bourke et al.. Heart Dis Stroke. 1994. Prevention of hypokalemia caused by diuretics. PubMed
  17. [17] T Dyckner et al.. Eur J Clin Pharmacol. 1986. Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial … doi:10.1007/BF00542411 PubMed
  18. [18] D L Kuchar et al.. Eur Heart J. 1985. High dose furosemide in refractory cardiac failure. doi:10.1093/oxfordjournals.eurheartj.a061793 PubMed
  19. [19] H L Macfie et al.. Drug Intell Clin Pharm. 1981. New drug evaluations amiloride (Midamor, Merck, Sharp and Dohme). doi:10.1177/106002808101500202 PubMed
  20. [20] G Lemieux et al.. Can Med Assoc J. 1980. Hypokalemia during the treatment of arterial hypertension with diuretics. PubMed
  21. [21] G Nuki et al.. Ann Rheum Dis. 1975. Potassium metabolism in patients with rheumatoid arthritis. Effects of treatment with depot tetracosactrin, spironolactone, and oral supplements of potassium chloride. doi:10.1136/ard.34.6.506 PubMed

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.